Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07704658	Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors	recruiting	Phase 4	12	Rigel PharmaceuticalsINDUSTRY	1	Aug 10, 2026	clinicaltrials
NCT07697287	Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based Treatment(TOPHAT)	active not recruiting	Phase 4	29	McMaster UniversityOTHER	1	Jul 13, 2026	clinicaltrials